Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Gelder

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Sensors (Basel, Switzerland)|July 29, 2023
A Single-Sensor Approach to Quantify Gait in Patients with Hereditary Spastic ParaplegiaLinda M A van Gelder, Tecla Bonci, Ellen E Buckley, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1985
Oncogenic evaluation of tetrachlorvinphos in the B6C3F1 mouseC M Parker, G A Van Gelder, E Y Chai, et al.
BMJ Open|September 28, 2013
Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care studyVincent A van Gelder, Nynke D Scherpbier-de Haan, Wim J C de Grauw, et al.
Journal of Medicinal Chemistry|August 1, 2024
Novel <i>N,N</i>-Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant CellsMerle A van Gelder, Yufeng Li, Dennis P A Wander, et al.
Annals of Family Medicine|March 20, 2013
Initial implementation of a web-based consultation process for patients with chronic kidney diseaseNynke D Scherpbier-de Haan, Vincent A van Gelder, Chris Van Weel, et al.
Life Sciences|August 18, 2004
In vivo measurements of the cerebral perfusion and cardiovascular effects of the novel guanidine ME10092 in the non-human primate, Papio ursinusD W Oliver, I C Dormehl, J E S Wikberg, et al.
Scandinavian Journal of Primary Health Care|February 9, 2016
Quality of chronic kidney disease management in primary care: a retrospective studyVincent A Van Gelder, Nynke D Scherpbier-De Haan, Wim J C De Grauw, et al.
Family Practice|February 17, 2017
Adherence to chronic kidney disease guidelines in primary care patients is associated with comorbidityCarola van Dipten, Saskia van Berkel, Vincent A van Gelder, et al.
Journal of Medicinal Chemistry|August 10, 2023
Re-Exploring the Anthracycline Chemical Space for Better Anti-Cancer CompoundsMerle A van Gelder, Sabina Y van der Zanden, Merijn B L Vriends, et al.
Molecular Cancer|June 3, 2024
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patientsXiaohang Qiao, Sabina Y van der Zanden, Xiaoyang Li, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Sensors (Basel, Switzerland)|July 29, 2023
A Single-Sensor Approach to Quantify Gait in Patients with Hereditary Spastic ParaplegiaLinda M A van Gelder, Tecla Bonci, Ellen E Buckley, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|October 1, 1985
Oncogenic evaluation of tetrachlorvinphos in the B6C3F1 mouseC M Parker, G A Van Gelder, E Y Chai, et al.
BMJ Open|September 28, 2013
Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care studyVincent A van Gelder, Nynke D Scherpbier-de Haan, Wim J C de Grauw, et al.
Journal of Medicinal Chemistry|August 1, 2024
Novel <i>N,N</i>-Dimethyl-idarubicin Analogues Are Effective Cytotoxic Agents for ABCB1-Overexpressing, Doxorubicin-Resistant CellsMerle A van Gelder, Yufeng Li, Dennis P A Wander, et al.
Annals of Family Medicine|March 20, 2013
Initial implementation of a web-based consultation process for patients with chronic kidney diseaseNynke D Scherpbier-de Haan, Vincent A van Gelder, Chris Van Weel, et al.
Life Sciences|August 18, 2004
In vivo measurements of the cerebral perfusion and cardiovascular effects of the novel guanidine ME10092 in the non-human primate, Papio ursinusD W Oliver, I C Dormehl, J E S Wikberg, et al.
Scandinavian Journal of Primary Health Care|February 9, 2016
Quality of chronic kidney disease management in primary care: a retrospective studyVincent A Van Gelder, Nynke D Scherpbier-De Haan, Wim J C De Grauw, et al.
Family Practice|February 17, 2017
Adherence to chronic kidney disease guidelines in primary care patients is associated with comorbidityCarola van Dipten, Saskia van Berkel, Vincent A van Gelder, et al.
Journal of Medicinal Chemistry|August 10, 2023
Re-Exploring the Anthracycline Chemical Space for Better Anti-Cancer CompoundsMerle A van Gelder, Sabina Y van der Zanden, Merijn B L Vriends, et al.
Molecular Cancer|June 3, 2024
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patientsXiaohang Qiao, Sabina Y van der Zanden, Xiaoyang Li, et al.
Pageof 6